170 related articles for article (PubMed ID: 37792729)
21. Electrochemotherapy in treatment of canine oral malignant melanoma and factors influencing treatment outcome.
Tellado MN; Maglietti FH; Michinski SD; Marshall GR; Signori E
Radiol Oncol; 2020 Mar; 54(1):68-78. PubMed ID: 32187017
[TBL] [Abstract][Full Text] [Related]
22. Anti-neoplastic effects of topoisomerase inhibitors in canine mammary carcinoma, melanoma, and osteosarcoma cell lines.
Ong SM; Yamamoto H; Saeki K; Tanaka Y; Yoshitake R; Nishimura R; Nakagawa T
Jpn J Vet Res; 2017 Feb; 65(1):17-28. PubMed ID: 29791117
[TBL] [Abstract][Full Text] [Related]
23. A combination of electrochemotherapy, gene electrotransfer of plasmid encoding canine IL-12 and cytoreductive surgery in the treatment of canine oral malignant melanoma.
Milevoj N; Tratar UL; Nemec A; Brožič A; Žnidar K; Serša G; Čemažar M; Tozon N
Res Vet Sci; 2019 Feb; 122():40-49. PubMed ID: 30453179
[TBL] [Abstract][Full Text] [Related]
24. Cancer immunology and canine malignant melanoma: A comparative review.
Atherton MJ; Morris JS; McDermott MR; Lichty BD
Vet Immunol Immunopathol; 2016 Jan; 169():15-26. PubMed ID: 26827834
[TBL] [Abstract][Full Text] [Related]
25. Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial.
Riccardo F; Tarone L; Camerino M; Giacobino D; Iussich S; Barutello G; Arigoni M; Conti L; Bolli E; Quaglino E; Merighi IF; Morello E; Dentini A; Ferrone S; Buracco P; Cavallo F
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580930
[TBL] [Abstract][Full Text] [Related]
26. RADIOTHERAPY AND CHEMOTHERAPY FOR DOMESTIC ANIMALS. II. TREATMENT OF MALIGNANT TUMOURS IN DOGS AND CATS.
SILVER IA; CATER DB
Acta Radiol Ther Phys Biol; 1964 Dec; 2():457-75. PubMed ID: 14245064
[No Abstract] [Full Text] [Related]
27. Phase II evaluation of doxorubicin for treatment of various canine neoplasms.
Ogilvie GK; Reynolds HA; Richardson RC; Withrow SJ; Norris AM; Henderson RA; Klausner JS; Fowler JD; McCaw D
J Am Vet Med Assoc; 1989 Dec; 195(11):1580-3. PubMed ID: 2599941
[TBL] [Abstract][Full Text] [Related]
28. Histologic evaluation of mandibular and medial retropharyngeal lymph nodes during staging of oral malignant melanoma and squamous cell carcinoma in dogs.
Grimes JA; Mestrinho LA; Berg J; Cass S; Oblak ML; Murphy S; Amsellem PM; Brown P; Hamaide A; Matz BM
J Am Vet Med Assoc; 2019 Apr; 254(8):938-943. PubMed ID: 30938614
[TBL] [Abstract][Full Text] [Related]
29. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model.
Hershey AE; Kurzman ID; Forrest LJ; Bohling CA; Stonerook M; Placke ME; Imondi AR; Vail DM
Clin Cancer Res; 1999 Sep; 5(9):2653-9. PubMed ID: 10499645
[TBL] [Abstract][Full Text] [Related]
30. Treatment of eight dogs with nasal tumours with alternating doses of doxorubicin and carboplatin in conjunction with oral piroxicam.
Langova V; Mutsaers AJ; Phillips B; Straw R
Aust Vet J; 2004 Nov; 82(11):676-80. PubMed ID: 15977611
[TBL] [Abstract][Full Text] [Related]
31. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
32. COX-1 and COX-2 expression in canine cutaneous, oral and ocular melanocytic tumours.
Pires I; Garcia A; Prada J; Queiroga FL
J Comp Pathol; 2010; 143(2-3):142-9. PubMed ID: 20207364
[TBL] [Abstract][Full Text] [Related]
33. Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision.
Dank G; Rassnick KM; Sokolovsky Y; Garrett LD; Post GS; Kitchell BE; Sellon RK; Kleiter M; Northrup N; Segev G
Vet Comp Oncol; 2014 Mar; 12(1):78-84. PubMed ID: 22737988
[TBL] [Abstract][Full Text] [Related]
34. Detection of novel polymorphisms in the ckit gene of canine patients with lymphoma, melanoma, haemangiosarcoma, and osteosarcoma.
Gramer I; Kessler M; Geyer J
Vet Res Commun; 2016 Jun; 40(2):89-95. PubMed ID: 26971271
[TBL] [Abstract][Full Text] [Related]
35. Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study.
Antonia S; Goldberg SB; Balmanoukian A; Chaft JE; Sanborn RE; Gupta A; Narwal R; Steele K; Gu Y; Karakunnel JJ; Rizvi NA
Lancet Oncol; 2016 Mar; 17(3):299-308. PubMed ID: 26858122
[TBL] [Abstract][Full Text] [Related]
36. Prospective clinical trial of masitinib mesylate treatment for advanced stage III and IV canine malignant melanoma.
Giuliano A; Dobson J
J Small Anim Pract; 2020 Mar; 61(3):190-194. PubMed ID: 31960455
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of dogs undergoing radiotherapy for treatment of oral malignant melanoma: 111 cases (2006-2012).
Kawabe M; Mori T; Ito Y; Murakami M; Sakai H; Yanai T; Maruo K
J Am Vet Med Assoc; 2015 Nov; 247(10):1146-53. PubMed ID: 26517618
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor.
Grosenbaugh DA; Leard AT; Bergman PJ; Klein MK; Meleo K; Susaneck S; Hess PR; Jankowski MK; Jones PD; Leibman NF; Johnson MH; Kurzman ID; Wolchok JD
Am J Vet Res; 2011 Dec; 72(12):1631-8. PubMed ID: 22126691
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of accuracy for
Willcox JL; Spriet M; Zwingenberger AL; Phillips KL; Burton JH; Skorupski KA; Hansen KS; Affolter VK; Woolard KD; Beylin D; Giuffrida MA
Vet Comp Oncol; 2021 Sep; 19(3):463-472. PubMed ID: 32892513
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti-CSPG4 vaccination: A retrospective study on 68 cases (2010-2020).
Camerino M; Giacobino D; Manassero L; Iussich S; Riccardo F; Cavallo F; Tarone L; Olimpo M; Lardone E; Martano M; Del Magno S; Buracco P; Morello E
Vet Comp Oncol; 2022 Mar; 20(1):189-197. PubMed ID: 34392602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
